|
| 37003903 | Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIV. | Enferm Infecc Microbiol Clin (Engl Ed) | 2024 |
| 37882613 | The Current Mismatch Between COVID-19 Clinical Trial Design and the Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis. | Clin Infect Dis | 2024 |
| 36303321 | Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in Reality. | Clin Infect Dis | 2023 |
| 37512990 | Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV. | Microorganisms | 2023 |
| 37148893 | Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. | Lancet Healthy Longev | 2023 |
| 37200995 | Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials. | EClinicalMedicine | 2023 |
| 37131861 | Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial. | Lancet Reg Health Eur | 2023 |
| 36624034 | Treatment and prevention of monkeypox. | Enferm Infecc Microbiol Clin (Engl Ed) | 2023 |
| 36806001 | Corrigendum to "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)". | EBioMedicine | 2023 |
| 36685004 | No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study. | Res Pract Thromb Haemost | 2023 |
| 36641054 | Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection. | Clin Microbiol Infect | 2023 |
| 36640455 | Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns. | EBioMedicine | 2023 |
| 36773626 | Need for clear inclusion criteria in reviews of antiretroviral treatments - Authors' reply. | Lancet HIV | 2023 |
| 36680782 | Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. | Br J Clin Pharmacol | 2023 |
| 35906838 | Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial. | Clin Infect Dis | 2023 |
| 34166509 | Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment. | J Infect Dis | 2022 |
| 35795713 | Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study. | EClinicalMedicine | 2022 |
| 35623577 | Immunocompromised patients have been neglected in COVID-19 trials: a call for action. | Clin Microbiol Infect | 2022 |
| 35848506 | Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients. | AIDS | 2022 |
| 36447613 | Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance. | Open Forum Infect Dis | 2022 |
| 35873289 | Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens. | Open Forum Infect Dis | 2022 |
| 36249471 | [Treatment and prevention of monkeypox]. | Enferm Infecc Microbiol Clin | 2022 |
| 36309038 | Two-drug regimens for HIV treatment. | Lancet HIV | 2022 |
| 35901108 | HIV and aging, biological mechanisms, and therapies: What do we know? | AIDS Rev | 2022 |
| 36382436 | Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection. | AIDS | 2022 |
| 34954640 | Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort. | Biomed Pharmacother | 2022 |
| 35045162 | Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults. | J Antimicrob Chemother | 2022 |
| 35249671 | Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort. | Enferm Infecc Microbiol Clin (Engl Ed) | 2022 |
| 34910812 | Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years. | J Infect Dis | 2022 |
| 35207411 | Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial. | J Clin Med | 2022 |
| 35338549 | Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021. | HIV Med | 2022 |
| 35323160 | Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV. | AIDS | 2022 |
| 35228014 | Ageing with HIV: Challenges and biomarkers. | EBioMedicine | 2022 |
| 35018404 | Past and future of HIV infection. A document based on expert opinion. | Rev Esp Quimioter | 2022 |
| 34763056 | Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. | Clin Microbiol Infect | 2022 |
| 34534138 | Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection. | AIDS | 2022 |
| 34414421 | Seasonal Coronavirus Pneumonia After SARS-CoV-2 Infection and Vaccination: New Frenemies? | J Infect Dis | 2022 |
| 32680795 | Impact of COVID-19 on Madrid hospital system. | Enferm Infecc Microbiol Clin (Engl Ed) | 2021 |
| 33794182 | Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial. | Lancet HIV | 2021 |
| 33734835 | Critical Care Requirements Under Uncontrolled Transmission of SARS-CoV-2. | Am J Public Health | 2021 |
| 33757850 | Presenting characteristics and outcomes of migrants in a cohort of hospitalized patients with COVID-19: Does the origin matter? | Travel Med Infect Dis | 2021 |
| 33557651 | Risks and benefits of reducing the number of drugs to treat HIV-1 infection. | Expert Opin Drug Saf | 2021 |
| 33556032 | Health Care Workers' Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study. | J Med Internet Res | 2021 |
| 33632764 | Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. | Thorax | 2021 |
| 34459889 | Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study). | J Antimicrob Chemother | 2021 |
| 34186209 | Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort. | Clin Microbiol Infect | 2021 |
| 34348449 | Overview of virus and cancer relationships. Position paper. | Rev Esp Quimioter | 2021 |
| 34324783 | COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study. | HIV Med | 2021 |
| 34116205 | The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis. | Clin Microbiol Infect | 2021 |
| 31405518 | Is Spain doing enough to reduce the cardiovascular risk of patients with Human Immnodeficiency Virus infection? | Rev Clin Esp (Barc) | 2020 |